title: Severe Eosinophilic Gastroenteritis in a Crohn's Disease Patient Treated With Infliximab and Adalimumab.
authors.affiliation: Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
authors.forename: Amanda
authors.initials: A
authors.lastname: Muir
authors.affiliation: Division of Pathology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
authors.forename: Lea
authors.initials: L
authors.lastname: Surrey
authors.affiliation: Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
authors.forename: Alyssa
authors.initials: A
authors.lastname: Kriegermeier
authors.affiliation: Division of Gastroenterology, Hepatology, and Nutrition, Nationwide Children's Hospital, Columbus, Ohio, USA.
authors.forename: Ala
authors.initials: A
authors.lastname: Shaikhkalil
authors.affiliation: Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
authors.forename: David A
authors.initials: DA
authors.lastname: Piccoli
mesh_terms: D000068879:Adalimumab / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D002648:Child; D003424:Crohn Disease / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D019468:Disease Management; D004351:Drug Resistance; D016099:Endoscopy, Gastrointestinal / Q000379:methods; D004751:Enteritis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D004802:Eosinophilia / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D005756:Gastritis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D000069285:Infliximab / Q000008:administration & dosage*; D008297:Male; D012008:Recurrence; D012720:Severity of Illness Index
chemical_list: D000893:Anti-Inflammatory Agents; D000069285:Infliximab; D000068879:Adalimumab